Pfizer has no interest in the cough diagnosis technology beyond the Covid test. Pfizer had plenty of opportunity to get involved and take over development of ResappDx, but not a whisper. No partnership. No ownership. No takeover. But the instant the Covid test appears as a possibility, Pfizer are in boots and all.
If the Covid test doesn't pan out ResappDx and the technology will just languish on the shelf.
Top-up fundraiser, page-242
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
